Skip to main content
. 2017 Mar 8;50(4):1075–1086. doi: 10.3892/ijo.2017.3905

Figure 7.

Figure 7

Kaplan-Meier plot of progression-free survival in OS patients using a cut-off of 2 CTCs per 7.5 ml peripheral blood. The ≥2 CTCs group had a median progression-free survival of 440 days, whereas the <2 CTCs group had a median progression-free survival of 547 days [P=0.0416, hazards ratio (log-rank) = 4.091, 95% CI of hazards ratio, 1.075–9.684].